| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |